<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25831005</article-id>
      <article-id pub-id-type="pmc">4371684</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153320</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Syndrome in Question</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Syndrome in Question<sup><xref ref-type="fn" rid="fn01">*</xref></sup></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>MA</surname>
            <given-names>Han</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Meilan</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Juan</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Ying</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Qiu</surname>
            <given-names>Shu</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <xref ref-type="corresp" rid="c01"/>
        <aff id="aff01"><label>1</label>Third Affiliated Hospital, Sun Yat-sen University -
Guangdong, China.</aff>
        <aff id="aff02"><label>2</label>First Affiliated Hospital, Sun Yat-sen University -
Guangdong, China</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Han Ma and Juan Li, Department of Dermatology,
Department of Hematology, Third Affiliated Hospital and First Affiliated Hospital,
Sun Yat-sen University, No. 600 Tianhe Road, Guangzhou, 510630 Guangdong, China.
E-mail: <email>drmahan@sina.com</email>; <email>drlijuan@sina.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Mar-Apr</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Mar-Apr</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>2</issue>
      <fpage>270</fpage>
      <lpage>271</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>12</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>1</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Immunoglobulin light chain amyloidosis is the most common acquired systemic
amyloidosis. Its presentation is often insidious and progressive, which may delay
diagnosis. The authors describe a rare case of immunoglobulin light chain amyloidosis
in a 34-year-old man with scleroderma-like manifestation substantiated by
multifarious laboratory investigations and the histopathologic feature of involved
skin lesions stained with Congo red and crystal violet. This helps to maintain a high
clinical suspicion of the disease when confronting similar skin presentation.</p>
      </abstract>
      <kwd-group>
        <kwd>Amyloidosis</kwd>
        <kwd>Scleroderma, diffuse</kwd>
        <kwd>Skin manifestations</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>CASE REPORT</title>
      <p>A 34-year-old man presented progressive generalized hardening of the body for 3 years.
Three months ago, he experienced difficulty in swallowing and extending his tongue, and
several hard nodules were noted progressively on the forehead (<xref ref-type="fig" rid="f01">Figure 1A</xref>). Physical examination revealed that the skin on his face
and distal extremities was indurated (<xref ref-type="fig" rid="f01">Figure 1B</xref>).
On the trunk and proximal extremities, the skin was normal in elasticity, but the
underlying muscles were indurated, and almost all the joints were restricted in motion.
No regional lymph nodes were palpable. Laboratory examination showed no abnormality in
routine tests. Serum and urine immunofixation showed a characteristic pattern of
monoclonal IgG gammopathy, particularly of &#x3BB; paraprotein. Some cardiac abnormalities
including left ventricular outflow obstruction and right ventricular dysfunction were
noted upon echocardiography. Positron emission tomography computed tomography (PET-CT)
scan showed multiple areas of abnormal uptake in almost all the joints and some muscles.
Bone marrow aspirate revealed active myeloid proliferation and 3% of plasmacyte
observed. Flow cytometry showed that CD38<sup>birght</sup> CD45<sup>dim/-</sup> cells
occupied 6.5% of all the nucleated cells and the expression of antigen was CD19 (0.7%),
CD56 (1.9%), CD20 (1.7%), CD54 (99.9%), CD138 (99.8%), CD49e (2.6%), intracytoplasmic
IgM (3.5%), intracytoplasmic IgD (0.5%), intracytoplasmic IgG (12.6%), intracytoplasmic
&#x3BA; paraprotein (0.3%) and intracytoplasmic &#x3BB; paraprotein (98.5%). There were no
remarkable findings in various other studies, including abdominal ultrasonography and
chest computer tomography (CT) scan. The skin and muscle biopsy specimens obtained from
the nodule on the forehead and inner thigh showed a deposition of amyloid materials in
the dermis, subcutaneous tissues, vessel walls and connective tissue septae of the
skeletal muscle, by Congo red and crystal violet stain (<xref ref-type="fig" rid="f01">Figure 1C</xref>, <xref ref-type="fig" rid="f01">1D</xref>, <xref ref-type="fig" rid="f01">1E</xref>, <xref ref-type="fig" rid="f01">1F</xref>, <xref ref-type="fig" rid="f01">1G</xref> and <xref ref-type="fig" rid="f01">1H</xref>). The diagnosis was
immunoglobulin light chain (AL) amyloidosis with scleroderma-like manifestation.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p><bold>A.</bold> Indurated skin on the face and macroglossia; <bold>B.</bold>
Indurated skin on the distal extremities; <bold>C.</bold> HE: deposition of
amyloid materials in the dermis and vessel walls; <bold>D.</bold> HE: deposition
of amyloid materials in the muscles; <bold>E.</bold> Red Congo stain highlighting
the amyloid substance in the vessel walls; <bold>F.</bold> Red Congo stain
highlighting the amyloid substance in the muscles; <bold>G.</bold> Crystal violet
stain revealing the amyloid substance in the vessel walls; <bold>(H)</bold>
Crystal violet stain revealing the amyloid substance in the muscles</p>
        </caption>
        <graphic xlink:href="abd-90-02-0270-g01"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Amyloidosis refers to a heterogeneous group of disorders characterized by extracellular
deposition of proteinaceous fibrillar materials (termed amyloid) in various tissues and
organs. Clinically, the most commonly affected organs resulting in symptoms are the
heart, kidneys, skin, peripheral nerves, autonomic nerves, and liver. Their respective
means of presentation are: 1) normal ejection fraction with diastolic dysfunction, left
ventricular hypertrophy with low voltage electrocardiogram; 2) nephrotic syndrome with
preserved glomerular filtration rate; 3) purpura, most notably around the eyes and neck,
as well as macroglossia; 4) small fiber peripheral neuropathy characterized by
dysesthesia; 5) orthostatic hypotension; 6) hepatomegaly, often with a cholestatic rise
in liver function tests.<sup><xref rid="r01" ref-type="bibr">1</xref></sup>
Mucocutaneous alterations are present in 20-40% of cases, frequently as the first signs
of amyloidosis.<sup><xref rid="r02" ref-type="bibr">2</xref></sup> In this patient,
however, it has rarely been seen only with scleroderma-like skin manifestation.</p>
      <p>At present, all treatments are aimed at destroying the underlying plasma cell clone,
which, in turn, reduces or eliminates the amyloidogenic clonal immunoglobulin light
chain. Currently, there are no approved drugs that directly attack and/or dissolve the
amyloid. The approach of using molecules and/or antibodies directed against serum
amyloid protein, or antibodies directed at the tertiary structure of the amyloid, may be
treatments for the future.<sup><xref rid="r03" ref-type="bibr">3</xref></sup></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interests: None</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: MA H, Chen M, Li J, Qiu S. Syndrome in question. An Bras
Dermatol. 2014;90(2):270-1.</p>
      </fn>
      <fn fn-type="other" id="fn01">
        <label>*</label>
        <p>Work performed at the the Third Affiliated Hospital and First Affiliated Hospital,
Sun Yat-sen University, Guangzhou, Guangdong, China.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dispenzieri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gertz</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Buadi</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>What do I need to know about immunoglobulin light chain (AL)
amyloidosis</article-title>
          <source>Blood Rev</source>
          <year>2012</year>
          <volume>26</volume>
          <fpage>137</fpage>
          <lpage>154</lpage>
          <pub-id pub-id-type="pmid">22537397</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lavorato</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Alves</surname>
              <given-names>M de F</given-names>
            </name>
            <name>
              <surname>Maceira</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Unterstell</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Serpa</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Azulay-Abulafia</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Primary systemic amyloidosis, acquired cutis laxa and cutaneous
mucinosis in a patient with multiple myeloma</article-title>
          <source>An Bras Dermatol</source>
          <year>2013</year>
          <volume>88</volume>
          <fpage>32</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">24346874</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bodin</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ellmerich</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kahan</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Tennent</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Loesch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gilbertson</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antibodies to human serum amyloid P component eliminate visceral
amyloid deposits</article-title>
          <source>Nature</source>
          <year>2010</year>
          <volume>468</volume>
          <fpage>93</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">20962779</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
